VisionQuest Biomedical Inc.
VisionQuest Biomedical was founded in 2007 with the goal of developing and commercializing advanced technologies aimed at preventing blindness and improving diabetes care. VisionQuest Biomedical, a technology-based healthcare diagnostics company, is making instant detection for Cerebral Malaria a reality for thousands through the use of Artificial Intelligence. VisionQuest Biomedical began with an idea — to simplify unpractical methods of diagnosing diabetic retinopathy in ever-increasing numbers of diabetes patients and bring cutting-edge Artificial Intelligence technology to everyday eye care. We develop AI to fit clinical applications. We don’t just design the AI in the lab, we use it in the clinics to make sure patients and doctors are satisfied. VisionQuest Biomedical is using Artificial Intelligence to revolutionize image-based diagnostics.
Company details
Find locations served, office locations
- Business Type:
- Software vendor
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2007
About Us
In just a few years, that idea has evolved into a series of software products that empower hospitals, healthcare centers and laboratories in the early detection of not only diabetic retinopathy, but also diabetic peripheral neuropathy (diabetic foot), cerebral malaria, and retinopathy of prematurity.
Our products and technology are currently and successfully being deployed in seven countries and have served more than 50,000 patients. With the coronavirus pandemic impacting many industries, testing solutions that are quick, accessible, and contactless are here to stay.
Mission
Our mission is to develop and deploy image-based technologies to improve access to health care for millions of individuals in the United States and around the world, especially in the fields of diabetes and eyecare.